Filter
1678
Filtered Results: 1678
Text search:
protein-based
Featured
Recommendations
216
New Publications
468
Language
Document type
No document type
892
Guidelines
319
Studies & Reports
237
Manuals
101
Fact sheets
45
Training Material
42
Strategic & Response Plan
25
Brochures
5
Situation Updates
4
Resource Platforms
3
Infographics
3
Videos
2
Countries / Regions
India
129
Global
60
Kenya
51
South Africa
38
Nepal
31
Uganda
31
Ethiopia
31
Nigeria
28
Tanzania
28
Sierra Leone
22
Rwanda
22
Indonesia
22
Namibia
20
Philippines
19
Bangladesh
19
Africa
18
Latin America and the Carribbean
18
Liberia
18
Zambia
17
Senegal
16
Malawi
16
Ghana
15
Myanmar / Burma
15
Russia
14
Western and Central Europe
12
West and Central Africa
11
Brazil
11
Lesotho
10
Venezuela
10
Congo, Democratic Republic of
10
East and Southern Africa
10
Syria
9
South Sudan
9
Ukraine
8
Germany
8
Mozambique
7
South–East Asia Region
7
Eastern Europe
7
Eswatini/ Swaziland
7
Zimbabwe
6
Middle East and North Africa
6
Yemen
6
Colombia
5
Cameroon
5
Guinea
5
USA
5
Madagascar
5
Chile
4
Haiti
4
Asia
4
Sudan
4
Mali
4
Botswana
4
Somalia
4
Benin
3
Burkina Faso
3
Afghanistan
3
Peru
3
Cambodia
3
Western Pacific Region
3
France
3
Papua New Guinea
3
Libya
3
Iraq
3
Ecuador
3
Pakistan
3
Mexico
2
Togo
2
Iran
2
Niger
2
Qatar
2
Italy
2
Jordan
2
Saudi Arabia
2
Eastern Europe and Central Asia
2
Spain
2
Lebanon
2
Egypt
2
Angola
2
Tajikistan
1
El Salvador
1
Gambia
1
China
1
Kazakhstan
1
Albania
1
Singapore
1
Congo-Brazzaville
1
Morocco
1
Mongolia
1
Mauritania
1
Dominican Republic
1
Paraguay
1
North America
1
Jamaica
1
Tunisia
1
United Kingdom
1
Portugal
1
Belarus
1
Israel
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Argentina
1
Nicaragua
1
Moldova
1
Djibouti
1
Palestine
1
Central African Republic
1
Honduras
1
Chad
1
Cuba
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
637
Clinical Guidelines
229
Women & Child Health
112
Public Health
98
Key Resources
78
Pharmacy & Technologies
40
Capacity Building
39
Toolboxes
COVID-19
166
TB
112
HIV
74
NTDs
74
Planetary Health
71
Mental Health
61
NCDs
54
AMR
53
Rapid Response
50
Caregiver
49
Malaria
44
Ebola & Marburg
43
Pharmacy
31
Conflict
31
Refugee
23
Global Health Education
16
Polio
10
Natural Hazards
8
Disability
7
Cholera
7
Zika
7
Specific Hazards
6
Health Financing Toolbox
4
Typhoon
1
This report investigates the impact of potential misclassification of samples on HIV prevalence estimates for 23 surveys conducted from 2010-2014. In addition to visual inspection of laboratory results, we examined how accounting for potential misclassification of HIV status through Bayesian latent ...
National AIDS and STI Control Program
Материалы научно-практической конференции с международным участием «Достижения в нейробиологии и терапии болезни Альцгеймера», посвященной памяти профессора Э....
Relapsing malaria caused by Plasmodium vivax parasites poses a significant challenge to global malaria elimination efforts. About one third of the population remains at risk of contracting P. vivax malaria, and 85% of P. vivax infections stem from reactivated latent parasites, leading to chronic ana...
The report aims to capture lessons from the COVID-19 pandemic and to highlight the opportunity for more ambitious global action: expanding sustainable access to vaccines for all towards the Immunization Agenda 2030 and pandemic prevention, preparedness and response efforts. The report is organized i...
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing for Middle East respiratory syndrome coronavirus (MERS-CoV).
Development of one or more vaccines for Neisseria gonorrhoeae is an important objective for sexual and reproductive health worldwide, and for the fight against antimicrobial resistance.
WHO preferred product characteristics (PPCs) provide strategic guidance as to WHO’s preferences for new vacci...
19 February 2018
The recommendations in this guideline are intended to inform development of national and subnational health policies, clinical protocols and programmatic guides. The target audience includes national and subnational public health policy-makers, implementers and managers of maternal, newborn and chil...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
Will COVID-19 vaccines be safe? Will all the COVID-19 candidate vaccines be successful? What are the different phases a vaccine must go through to be approved? This document provides responses to the most frequently asked questions about candidate vaccines and access to COVID-19 vaccination.
Updated 28 December 2020
Preferred product characteristics and clinical development considerations
